Näytetään tulokset 1 - 10 / 70
tulosta / sivu
Mitä julkaisutietoja palvelu sisältää?
Julkaisun nimi
Tekijät
Julkaisukanava
Vuosi

Real-world pharmacogenetics of statin intolerance: effects of SLCO1B1, ABCG2 , and CYP2C9 variants

Vertaisarvioitu
Avoin saatavuus
DOI
10.1097/FPC.0000000000000504
Lönnberg, K. Ivar; Tornio, Aleksi; Hirvensalo, Päivi; Keskitalo, Jenni; Mustaniemi, Anna-Liina; Kiis...
Pharmacogenetics and genomics2023

Exploring pharmacogenetics in drug discovery and development. Impact of pharmacogenetics on drug discovery and development

Pelkonen, Olavi
CIOMS2005

Post-mortem analysis of suicide victims shows ABCB1 haplotype 1236T-2677T-3435T as a candidate predisposing factor behind adverse drug reactions in females

Vertaisarvioitu
Avoin saatavuus
DOI
10.1097/FPC.0000000000000328
Rahikainen, Anna-Liina; Palo, Jukka U.; Haukka, Jari; Sajantila, Antti
Pharmacogenetics and genomics2018

SLCO1B1 polymorphism markedly affects the pharmacokinetics of lovastatin acid

Vertaisarvioitu
DOI
10.1097/FPC.0000000000000148
Tornio, Aleksi; Vakkilainen, Juha; Neuvonen, Mikko; Backman, Janne T.; Neuvonen, Pertti J.; Niemi, M...
Pharmacogenetics and genomics2015

A polymorphism in the protein kinase C gene PRKCB is associated with alpha(2)-adrenoceptor-mediated vasoconstriction

Vertaisarvioitu
Posti, Jussi P.; Salo, Perttu; Ruohonen, Saku; Valve, Laura; Muszkat, Mordechai; Sofowora, Gbenga G....
Pharmacogenetics and genomics2013

PharmGKB summary: very important pharmacogene information for cytochrome P450, family 2, subfamily C, polypeptide 8

Vertaisarvioitu
DOI
10.1097/FPC.0b013e3283653b27
Aquilante, Christina L.; Niemi, Mikko; Gong, Li; Altman, Russ B.; Klein, Teri E.
Pharmacogenetics and genomics2013

"SLCO2B1 c.935G > A single nucleotide polymorphism has no effect on the pharmacokinetics of montelukast and aliskiren"

Vertaisarvioitu
DOI
10.1097/FPC.0b013e32835bac90
Tapaninen, Tuija; Karonen, Tiina; Backman, Janne T.; Neuvonen, Pertti J.; Niemi, Mikko
Pharmacogenetics and genomics2013

Similarity in recombination rate and linkage disequilibrium at CYP2C and CYP2D cytochrome P450 gene regions among Europeans indicates signs of selection and no advantage of using tagSNPs in population isolates

Vertaisarvioitu
DOI
10.1097/FPC.0b013e32835a3a6d
Pimenoff, Ville N.; Laval, Guillaume; Comas, David; Palo, Jukka U.; Gut, Ivo; Cann, Howard; Excoffie...
Pharmacogenetics and genomics2012

Catechol-O-methyltransferase gene polymorphism and chronic human pain: a systematic review and meta-analysis

Vertaisarvioitu
DOI
10.1097/FPC.0b013e3283560c46
Männistö, Pekka T.; Tammimäki, Anne
Pharmacogenetics and Genomics2012

Genetic polymorphisms of xenobiotic-metabolizing enzymes influence the risk of pulmonary emphysema

Vertaisarvioitu
Kukkonen, Mari K.; Hämäläinen, Satu; Kaleva, Simo; Vehmas, Tapio; Huuskonen, Matti; Oksa, Panu; Vain...
Pharmacogenetics and genomics2011

Real-world pharmacogenetics of statin intolerance: effects of SLCO1B1, ABCG2 , and CYP2C9 variants

Vertaisarvioitu
Avoin saatavuus
DOI
10.1097/FPC.0000000000000504
2023

Exploring pharmacogenetics in drug discovery and development. Impact of pharmacogenetics on drug discovery and development

2005

Post-mortem analysis of suicide victims shows ABCB1 haplotype 1236T-2677T-3435T as a candidate predisposing factor behind adverse drug reactions in females

Vertaisarvioitu
Avoin saatavuus
DOI
10.1097/FPC.0000000000000328
2018

SLCO1B1 polymorphism markedly affects the pharmacokinetics of lovastatin acid

Vertaisarvioitu
DOI
10.1097/FPC.0000000000000148
2015

A polymorphism in the protein kinase C gene PRKCB is associated with alpha(2)-adrenoceptor-mediated vasoconstriction

Vertaisarvioitu
2013

PharmGKB summary: very important pharmacogene information for cytochrome P450, family 2, subfamily C, polypeptide 8

Vertaisarvioitu
DOI
10.1097/FPC.0b013e3283653b27
2013

"SLCO2B1 c.935G > A single nucleotide polymorphism has no effect on the pharmacokinetics of montelukast and aliskiren"

Vertaisarvioitu
DOI
10.1097/FPC.0b013e32835bac90
2013

Similarity in recombination rate and linkage disequilibrium at CYP2C and CYP2D cytochrome P450 gene regions among Europeans indicates signs of selection and no advantage of using tagSNPs in population isolates

Vertaisarvioitu
DOI
10.1097/FPC.0b013e32835a3a6d
2012

Catechol-O-methyltransferase gene polymorphism and chronic human pain: a systematic review and meta-analysis

Vertaisarvioitu
DOI
10.1097/FPC.0b013e3283560c46
2012

Genetic polymorphisms of xenobiotic-metabolizing enzymes influence the risk of pulmonary emphysema

Vertaisarvioitu
2011